appConfigEntityId

bodyType

customContents

entityId

entityUuid

isVideo

articlePageQuery

article

articleSchemaContent

content

hooksArticlePageAdvertisementConfigArticle

hooksArticlePageFloatingButtonConfigArticle

appConfig

filter

json

liveArticle

Dannie Peng

A promising new vaccine candidate has been developed by Chinese scientists to combat African swine fever, a highly contagious virus in pigs which can have a mortality rate as high as 100 per cent.
The virus has devastated the pork industry globally in recent years, according to Weng Changjiang, co-author of the research detailing the potential vaccine.
“It has resulted in economic losses of hundreds of billions of yuan for the swine industry, affecting the livelihoods of many people and industry development,” he told the Post on Tuesday.
Currently, there is no vaccine that is effective against the swine fever virus. Instead, governments around the world have sought to control and prevent the disease by culling herds, restricting the transport of pigs and improving hygiene on farms.
Vaccines generally work by stimulating the immune system, including antibodies, to defend against a particular virus or bacteria. To achieve this, vaccines show the body a harmless version of the pathogen, or part of it so that it can remember it.
For this vaccine candidate, Weng’s team designed a live but weakened version of the virus to trigger a strong immune reaction.


To do this, the scientists deleted two highly pathogenic genes previously identified in the African swine fever virus to create a new mutant.
This was then administered to two groups of five pigs – grouped as low-dose and high-dose. All the animals developed detectable antibodies.
After 28 days, the pigs were then given the virus.
The results showed that all vaccinated pigs survived the illness. A few animals in the low-dose group exhibited mild, brief clinical symptoms with the virus detectable in their blood, but no significant tissue lesions were found.
Meanwhile a control group of pigs which were not given the vaccine died within 10 to 12 days of contracting the virus.
The vaccine research was conducted by a group of scientists from Harbin Veterinary Research Institute, under the Chinese Academy of Agricultural Sciences, with the findings published last month in the peer-reviewed Journal of Virology.
While African swine fever is not dangerous to humans, the current global outbreak has led to the loss of 1.5 million animals through the virus and culling since January 2021, with Europe the hardest hit region, according to the latest statistics from the World Organisation for Animal Health (WOAH) released in September.
100 pigs at Hong Kong farm culled over 32 cases of African swine fever
During that time, 974,335 domestic pigs and 29,301 wild boars were confirmed to be infected with the virus.
“This spread confirms the global threat of the disease and highlights the importance of implementing biosecurity measures, an early reporting and response system, and maintaining a high level of disease awareness among all actors involved in the value chain,” WOAH said.
The deadly virus swept across China from 2018 to 2020, slashing herds in the world’s biggest producer and consumer of pork, leading to an increase in imports and sending meat costs soaring. It also spread into other Asian countries before showing up in Europe.
Since 2018, the Chinese government has launched many scientific initiatives to tackle the disease, from a basic understanding of the virus to vaccine development.
Weng and his colleagues started their research at the end of 2018.
“We began from ‘zero’,” he said, but over the last five years, his team has achieved many world-leading breakthroughs.

African swine fever was first identified in 1921 in Kenya. In the past three decades, finding a safe and effective vaccine has been a global effort – but it has so far proved elusive.
An example of that global bid to develop a vaccine can be seen in the work being done by scientists at the Agriculture Research Service of the US Department of Agriculture (USDA).
Their approach involves deleting a specific gene, and in April 2022, the USDA announced the successful completion of a key safety test required for regulatory approval.
“We addressed some unclear issues in basic research by extensively screening more than 180 genes of this virus,” Weng said, noting that his team has identified a crucial structural protein, one of the two pathogenic genes mentioned earlier.
The knowledge equates to a big leap in the field. It allows the vaccinated pigs to avoid infecting other animals they come into contact with, and prevents more pigs from being culled.
Vietnam partners with US to develop first African swine fever vaccine
Weng also said that the vaccine candidate did not show any adverse reactions, such as prolonged fever, after being administered. It is also a simple immunisation protocol, requiring just a single dose.
But, Weng said, there is still a long way to go before the vaccine becomes commercially viable, with technical, regulatory and financial hurdles to jump.
USDA microbiologist Douglas Gladue declined to comment on the experimental vaccine from the Chinese team, telling the Post: “A lot more data or studies are needed to bring a vaccine to market.”
At the beginning of this year, Hong Kong authorities culled about 100 pigs at a farm in Sheung Shui after 32 of the animals tested positive for African swine fever.
And in July, to prevent the spread of the disease, China’s General Administration of Customs and the Ministry of Agriculture and Rural Affairs announced a prohibition on the direct or indirect import of pigs, wild boars and their products from Croatia.


Why claims that China’s BeiDou satellite was refuelled in orbit could change space race

Offshore wind farm could create radar blind spots and ‘ghost’ targets, Chinese study warns

China tested a handheld submarine detector. It tracked a subway train underground

How Wang Zhenyi, Chinese female astronomer and mathematician, defied gender expectations

Science

Promising results as Chinese vaccine trial sees African swine fever fatality rate fall to zero

A potential vaccine for African swine fever being developed by Chinese scientists has showed promising results. Photo: EPA-EFE

The global outbreak of African swine fever, which swept across China in 2018, has devastated the pork industry. Pork: Bloomberg

‘We are overjoyed’: Chinese mRNA researchers celebrate Nobel win for field’s pioneers

Researchers are trying to improve the stability, shelf life and storage of mRNA vaccines. Photo: AP

‘Very promising’: Chinese herbal medicine trial offers new hope in memory loss treatment

Capsules containing a blend of Ginkgo biloba, ginseng and saffron extracts - called Sailuotong - have shown promise in improving memory and other functions in people diagnosed with mild cognitive impairment. Photo: Bloomberg

News

China

While African swine fever has a high mortality rate, in testing the Chinese-developed vaccine candidate, there were no fatalities
The virus outbreak has devastated the global pork industry in recent years, with 1.5 million animals lost since January 2021


Chinese scientists reveal fatalities were reduced to zero after testing of potential vaccine.


African swine fever

Croatia